US38341P1021
US38341P1021
Gossamer Bio, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 56.94M EUR | 80.66M EUR | 77.22M EUR | 724.4M EUR |
Enterprise Value | 43.41M EUR | 79.58M EUR | 239.12M EUR | 889.57M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -0.6x | -- | -- | -- |
Price to Sales | 1.07x | 1.51x | 1.39x | 18.78x |
Price to Book | -- | -- | -- | -- |
EV/Revenue | 0.82x | 1.49x | 4.31x | 23.06x |
EV/EBITDA | -0.27x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -52.27% | -201.62% | -220.57% | -18.17% |